As evidence builds, including real-world injury reports and now peer-reviewed clinical research, attorneys expect a wave of additional claims in the coming months involving Ozempic, Wegovy, Mounjaro, Zepbound, and other GLP-1 drugs
UK Medical Evidence Ozempic (semaglutide) is a GLP-1 receptor agonist licensed in the UK for treating type 2 diabetes
Semaglutide, being a synthetic GLP-1 receptor agonist, replicates these actions
Read clinical review Calibrate prescribes Wegovy (semaglutide 2.4 mg) as part of a metabolic health program combining GLP-1 therapy with lifestyle coaching
Here's how the consultation
If youre ready to see whether Ipamorelin, Sermorelin, or a combination is right for you, schedule a consultation today